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benefit, whereas gating, real tracking and MidV principle 
showed inferior advantage. The dose benefit showed 
statistical significance (p<0.05) for 9 patients in the case of 
ideal tracking, 8 patients for real tracking, 6 for gating and 5 
for MidV. Dose benefit was also organ-specifically averaged 
and mean values, standard deviations and p-values are shown 
in Tab. 1 for spinal cord, liver, ipsilateral kidney, ipsilateral 
lung and stomach. 
 
 
 
 
Conclusions: All investigated techniques resulted in PTV 
reduction and lower dose to the OARs compared to the ITV 
concept and should be considered for patients with moving 
tumors. With the simulated ideal tracking, the potential 
extend of benefit for tracking was shown, compared to gating 
and MidV principle. Realistic tracking by use of our in-housed 
developed system currently performs dosimetrically similar 
to gating or MidV technique.  
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Purpose/Objective: The aim of this study is to assess 
accuracy and efficiency of a novel approach to mitigate and 
track target motion during hypo-fractionated prostate cancer 
treatment. 
Materials and Methods: In our institution, most patients with 
low and intermediate risk prostate cancer are treated with 5 
times 9 Gy to the PTV, which consists of the CTV + 2mm. 
Patients anatomy reproducibility is improved by virtue of a 
rectal balloon with a personalized volume of air (median 
150cc). Three beacon transponders are placed intra-
urethrally by means of a Foley catheter to identify anatomy 
and allow intra-fractional tracking with the Calypso system 
(Varian). Before beam delivery, CBCTs are acquired and the 
6DoF couch is moved to closely match the reference 
treatment position. Thus, the Calypso system is reset to zero, 
and the treatment is started with tracking in place. 
Whenever motion beyond 2mm is detected for at least 5 
seconds, treatment will be interrupted.  
We used raw Calypso data instead of the zero-corrected data 
for motion analysis. First, raw Calypso readings were offset 
corrected by subtraction of the mean reading during 
reference CBCT acquisition, using linac log files for CBCT 
timings. Couch shifts between reference CBCT and treatment 
were corrected using table positions from ARIA. We then 
determined per fraction the mean corrected Calypso position 
(mf) and the standard deviation (sdf) during beam delivery. 
This yielded means (mp=<mf>) and SD (sdp=SD(mf)) per 
patient. Finally, the overall mean (μ=<mp>), the systematic 
(Σ=SD(mp)), and the inter- (σinter=<sdp>) and intra-fraction 
(σintra=<sdf>) random uncertainties were used to characterize 
the accuracy of our approach. Overall treatment duration, 
#CBCTs, and beam delivery times are established using the 
ARIA database. 
 
Results 
 
The table summarizes treatment times and motion results. 
We analysed 291 fractions from our first 63 five-fraction 
treatments. On average, 2.5 CBCTs were acquired prior to 
and 1 after start of beam delivery. Total treatment time 
lasted on average 20 minutes, of which 15 minutes 
preparation time and 5 minutes beam delivery time. With 
growing experience, treatment has become faster (from 24 to 
18 min). In total 20 treatment interruptions (7%) were 
needed. Regarding motion analysis, for 169 fractions of 43 
patients all required data were available. Sub-millimetre 
accuracy was observed in all directions resulting in margins 
(for the beacon motions only) < 2mm. Nevertheless, the 
accuracy and the treatment duration can be further 
improved. For instance, Calypso should always be reset to 
zero during and not after acquisition of the reference CBCT 
to avoid e.g. false-negatives due to the gradual beacon 
motions. 
Conclusions: Our novel approach for prostate positioning 
keeps the average target motions within 2mm. Further fine-
tuning of the procedure should make the intra-fraction 
motions truly negligible.  
 
 
 
